PUBLISHER: Grand View Research | PRODUCT CODE: 1571710
PUBLISHER: Grand View Research | PRODUCT CODE: 1571710
The global tonometer market size is expected to reach USD 630.8 million by 2030, expanding at a CAGR of 6.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rapidly increasing geriatric population and improving life expectancy are some of the major factors expected to contribute toward market growth. People aged 60 and above have an increased risk of developing glaucoma. As these devices play a significant role in the diagnosis and management of glaucoma, the market is anticipated to witness significant growth over the forecast period.
According to the Glaucoma Research Foundation, people with diabetes are twice as likely to develop glaucoma as compared to non-diabetics. Additionally, the International Diabetes Federation reported that around 463 million adults (aged 20-79 years) were living with diabetes in 2019, and the number is expected to reach 700 million by 2045. Increasing prevalence of glaucoma risk factors, such as myopia, hypertension, and diabetes, is expected to drive the demand for advanced tonometers in the long run. These devices significantly reduce the risk of infection, are highly convenient and easy to use, and can be used at home as well once the patients have been trained.
A large number of government and non-government initiatives, such as eye screening programs, state and national eye check-up camps, and ophthalmic awareness drives, are expected to play a significant role in boosting awareness about advanced tonometers. More than 90.0% cases of glaucoma remain undiagnosed in developing countries such as India. Such initiatives help increase the reach and awareness of glaucoma and its early diagnosis.
Frequent introduction of advanced tonometers is an emerging trend in the market. For instance, Icare ic100 by Icare Finland measures IOP at greater accuracy, eliminating the need for general/topical anesthesia or any air puff pressure.